abstract |
The present invention is useful as a prodrug of an inhibitor of trypsin-type protease, such as thrombin, and in particular in the treatment of diseases (eg, thrombosis) requiring inhibition of thrombin or as an anticoagulant: R 1 O (O ) C-CH 2- ( R ) Cgl-Aze-Pab-R 2 , wherein R 1 and R 2 have the meanings defined in the specification. |